Alabama Got Injectable Products, But None Contaminated
Alabama Got Injectable Products, But None Contaminated
Alabama health officials say 10 health care facilities in Alabama received sterile injectable products from a pharmacy involved in a fungal meningitis outbreak nationwide.
New England Compounding Center has voluntarily recalled all of its products pending results from the investigation. Although no Alabama health care facilities received the initially recalled contaminated product, 10 health care facilities did receive other NECC sterile injectable products. The Alabama Department of Public Health has contacted all facilities and they have been instructed to stop using them. All clinics, hospitals and health care providers that have the recalled product should stop using it immediately, retain and secure it, and contact NECC.
Dr. Mary McIntyre, acting state epidemiologist for ADPH, stated, “As the 23 states contact all patients (up to 14,000) who received one of the three contaminated lots of methylprednisolone acetate (a steroid), Alabama residents who received treatment in other states may be involved and contacted by their health care provider or public health. As the ongoing investigation expands to more products, this increases the possibility that Alabama residents received NECC products.”
The ADPH reports that at this time there is no evidence to indicate that products other than the three initial NECC lots are contaminated. There is also no evidence at this time that any of the NECC products received by Alabama’s facilities are contaminated.
A Health Alert Network message will be sent to all physicians to let them know about the products recalled and what to do with patients who present with symptoms. This type of meningitis is not contagious, and it cannot be spread from person to person. The symptoms include fever, headache (new symptoms or worsening), onset of stiff neck or sensitivity to light, or symptoms suggestive of a stroke such as slurred speech, difficulty walking, or increased dizziness or falls.
The ADPH recommends that Alabama residents who have had an epidural steroid injection since May 21, 2012, and have any of the following symptoms, should talk to their doctor as soon as possible:
- New or worsening headache
- Fever
- Sensitivity to light
- Stiff neck
- New weakness or numbness in any part of your body
- Slurred speech
- Increased pain, redness or swelling at your injection site
Additional information, including a list of states involved, is available at the CDC’s website.
Alabama Power seeks to delay rate hike for new gas plant amid outcry
The state’s largest utility has proposed delaying the rate increase from its purchase of a $622 million natural gas plant until 2028.
Former U.S. Sen. Doug Jones announces run for Alabama governor
Jones announced his campaign Monday afternoon, hours after filing campaign paperwork with the Secretary of State's Office. His gubernatorial bid could set up a rematch with U.S. Sen. Tommy Tuberville, the Republican who defeated Jones in 2020 and is now running for governor.
Scorching Saturdays: The rising heat threat inside football stadiums
Excessive heat and more frequent medical incidents in Southern college football stadiums could be a warning sign for universities across the country.
The Gulf States Newsroom is hiring an Audio Editor
The Gulf States Newsroom is hiring an Audio Editor to join our award-winning team covering important regional stories across Mississippi, Alabama and Louisiana.
Judge orders new Alabama Senate map after ruling found racial gerrymandering
U.S. District Judge Anna Manasco, appointed by President Donald Trump during his first term, issued the ruling Monday putting a new court-selected map in place for the 2026 and 2030 elections.
Construction on Meta’s largest data center brings 600% crash spike, chaos to rural Louisiana
An investigation from the Gulf States Newsroom found that trucks contracted to work at the Meta facility are causing delays and dangerous roads in Holly Ridge.
